Cargando…
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features
This study aimed to explore the correlation between imaging patterns and clinical features in patients with smoldering multiple myeloma (SMM) who simultaneously underwent 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor positron emission tomography/computed tomography (PET/CT). We retrieved and analyzed...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465161/ https://www.ncbi.nlm.nih.gov/pubmed/32824832 http://dx.doi.org/10.3390/cancers12082333 |
_version_ | 1783577526931554304 |
---|---|
author | Zhou, Xiang Dierks, Alexander Kertels, Olivia Kircher, Malte Schirbel, Andreas Samnick, Samuel Buck, Andreas K. Knorz, Sebastian Böckle, David Scheller, Lukas Messerschmidt, Janin Barakat, Mohammad Kortüm, K. Martin Rasche, Leo Einsele, Hermann Lapa, Constantin |
author_facet | Zhou, Xiang Dierks, Alexander Kertels, Olivia Kircher, Malte Schirbel, Andreas Samnick, Samuel Buck, Andreas K. Knorz, Sebastian Böckle, David Scheller, Lukas Messerschmidt, Janin Barakat, Mohammad Kortüm, K. Martin Rasche, Leo Einsele, Hermann Lapa, Constantin |
author_sort | Zhou, Xiang |
collection | PubMed |
description | This study aimed to explore the correlation between imaging patterns and clinical features in patients with smoldering multiple myeloma (SMM) who simultaneously underwent 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor positron emission tomography/computed tomography (PET/CT). We retrieved and analyzed clinical characteristics and PET imaging data of 10 patients with SMM. We found a significant correlation between bone marrow (BM) plasma cell (PC) infiltration and mean standardized uptake values (SUV(mean)) of lumbar vertebrae L2-L4 on 11C-Methionine PET/CT scans (r = 0.676, p = 0.031) and 68Ga-Pentixafor PET/CT scans (r = 0.839, p = 0.002). However, there was no significant correlation between BM involvement and SUV(mean) of lumbar vertebrae L2-L4 on 18F-FDG PET/CT scans (r = 0.558, p = 0.093). Similarly, mean target-to-background ratios (TBR(mean)) of lumbar vertebrae L2-L4 also correlated with bone marrow plasma cell (BMPC) infiltration in 11C-Methionine PET/CT (r = 0.789, p = 0.007) and 68Ga-Pentixafor PET/CT (r = 0.724, p = 0.018) PET/CT. In contrast, we did not observe a significant correlation between BMPC infiltration rate and TBR(mean) in 18F-FDG PET/CT (r = 0.355, p = 0.313). Additionally, on 11C-Methionine PET/CT scans, we found a significant correlation between BMPC infiltration and TBR(max) of lumbar vertebrae L2-L4 (r = 0.642, p = 0.045). In conclusion, 11C-Methionine and 68Ga-Pentixafor PET/CT demonstrate higher sensitivity than 18F-FDG PET/CT in detecting BM involvement in SMM. |
format | Online Article Text |
id | pubmed-7465161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74651612020-09-04 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features Zhou, Xiang Dierks, Alexander Kertels, Olivia Kircher, Malte Schirbel, Andreas Samnick, Samuel Buck, Andreas K. Knorz, Sebastian Böckle, David Scheller, Lukas Messerschmidt, Janin Barakat, Mohammad Kortüm, K. Martin Rasche, Leo Einsele, Hermann Lapa, Constantin Cancers (Basel) Article This study aimed to explore the correlation between imaging patterns and clinical features in patients with smoldering multiple myeloma (SMM) who simultaneously underwent 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor positron emission tomography/computed tomography (PET/CT). We retrieved and analyzed clinical characteristics and PET imaging data of 10 patients with SMM. We found a significant correlation between bone marrow (BM) plasma cell (PC) infiltration and mean standardized uptake values (SUV(mean)) of lumbar vertebrae L2-L4 on 11C-Methionine PET/CT scans (r = 0.676, p = 0.031) and 68Ga-Pentixafor PET/CT scans (r = 0.839, p = 0.002). However, there was no significant correlation between BM involvement and SUV(mean) of lumbar vertebrae L2-L4 on 18F-FDG PET/CT scans (r = 0.558, p = 0.093). Similarly, mean target-to-background ratios (TBR(mean)) of lumbar vertebrae L2-L4 also correlated with bone marrow plasma cell (BMPC) infiltration in 11C-Methionine PET/CT (r = 0.789, p = 0.007) and 68Ga-Pentixafor PET/CT (r = 0.724, p = 0.018) PET/CT. In contrast, we did not observe a significant correlation between BMPC infiltration rate and TBR(mean) in 18F-FDG PET/CT (r = 0.355, p = 0.313). Additionally, on 11C-Methionine PET/CT scans, we found a significant correlation between BMPC infiltration and TBR(max) of lumbar vertebrae L2-L4 (r = 0.642, p = 0.045). In conclusion, 11C-Methionine and 68Ga-Pentixafor PET/CT demonstrate higher sensitivity than 18F-FDG PET/CT in detecting BM involvement in SMM. MDPI 2020-08-18 /pmc/articles/PMC7465161/ /pubmed/32824832 http://dx.doi.org/10.3390/cancers12082333 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhou, Xiang Dierks, Alexander Kertels, Olivia Kircher, Malte Schirbel, Andreas Samnick, Samuel Buck, Andreas K. Knorz, Sebastian Böckle, David Scheller, Lukas Messerschmidt, Janin Barakat, Mohammad Kortüm, K. Martin Rasche, Leo Einsele, Hermann Lapa, Constantin 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features |
title | 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features |
title_full | 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features |
title_fullStr | 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features |
title_full_unstemmed | 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features |
title_short | 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features |
title_sort | 18f-fdg, 11c-methionine, and 68ga-pentixafor pet/ct in patients with smoldering multiple myeloma: imaging pattern and clinical features |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465161/ https://www.ncbi.nlm.nih.gov/pubmed/32824832 http://dx.doi.org/10.3390/cancers12082333 |
work_keys_str_mv | AT zhouxiang 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT dierksalexander 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT kertelsolivia 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT kirchermalte 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT schirbelandreas 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT samnicksamuel 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT buckandreask 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT knorzsebastian 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT bockledavid 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT schellerlukas 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT messerschmidtjanin 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT barakatmohammad 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT kortumkmartin 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT rascheleo 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT einselehermann 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures AT lapaconstantin 18ffdg11cmethionineand68gapentixaforpetctinpatientswithsmolderingmultiplemyelomaimagingpatternandclinicalfeatures |